Panama - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPanama: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024
Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Panama
The Panamanian prophylactic medicaments containing insulin market reached $X in 2022, flattening at the previous year. In general, consumption continues to indicate strong growth. Prophylactic medicaments containing insulin consumption peaked at $X in 2020; afterwards, it flattened through to 2022.
Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Panama
In value terms, prophylactic medicaments containing insulin production totaled $X in 2022 estimated in export price. Over the period under review, production showed strong growth. The pace of growth was the most pronounced in 2017 when the production volume increased by 26% against the previous year. Over the period under review, production attained the maximum level at $X in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.
Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Exports from Panama
After three years of decline, overseas shipments of medicaments containing insulin but not antibiotics in measured doses increased by 158% to X tons in 2022. Overall, exports, however, continue to indicate a pronounced decline. Over the period under review, the exports attained the maximum at X tons in 2016; however, from 2017 to 2022, the exports failed to regain momentum.
In value terms, prophylactic medicaments containing insulin exports surged to $X in 2022. Over the period under review, exports, however, continue to indicate a deep contraction. The pace of growth appeared the most rapid in 2018 with an increase of 78%. The exports peaked at $X in 2016; however, from 2017 to 2022, the exports remained at a lower figure.
Exports by Country
Barbados (X tons) was the main destination for prophylactic medicaments containing insulin exports from Panama, with a 71% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Barbados exceeded the volume sent to the second major destination, Jamaica (X tons), threefold.
From 2012 to 2022, the average annual rate of growth in terms of volume to Barbados totaled +71.2%. Exports to the other major destinations recorded the following average annual rates of exports growth: Jamaica (+42.3% per year) and Bermuda (+18.1% per year).
In value terms, Barbados ($X), Jamaica ($X) and Bermuda ($X) appeared to be the largest markets for prophylactic medicaments containing insulin exported from Panama worldwide, with a combined 99% share of total exports.
In terms of the main countries of destination, Barbados, with a CAGR of +77.3%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, falling by -51.7% against the previous year. Overall, the export price recorded a noticeable reduction. The most prominent rate of growth was recorded in 2018 when the average export price increased by 35% against the previous year. The export price peaked at $X per ton in 2019; however, from 2020 to 2022, the export prices stood at a somewhat lower figure.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Bermuda ($X per ton), while the average price for exports to Barbados ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Venezuela (+25.4%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Imports into Panama
In 2022, after two years of decline, there was significant growth in overseas purchases of medicaments containing insulin but not antibiotics in measured doses, when their volume increased by 16% to X tons. Over the period under review, imports, however, faced a deep downturn. The pace of growth appeared the most rapid in 2016 when imports increased by 139% against the previous year. As a result, imports attained the peak of X tons. From 2017 to 2022, the growth of imports remained at a somewhat lower figure.
In value terms, prophylactic medicaments containing insulin imports skyrocketed to $X in 2022. In general, imports, however, continue to indicate a deep slump. The pace of growth appeared the most rapid in 2019 when imports increased by 226% against the previous year. Imports peaked at $X in 2014; however, from 2015 to 2022, imports failed to regain momentum.
Imports by Country
In 2022, Denmark (X tons) constituted the largest supplier of prophylactic medicaments containing insulin to Panama, accounting for a 71% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Denmark exceeded the figures recorded by the second-largest supplier, Free Zones (X tons), fivefold.
From 2012 to 2022, the average annual rate of growth in terms of volume from Denmark totaled -6.6%. The remaining supplying countries recorded the following average annual rates of imports growth: Free Zones (+516.8% per year) and France (+0.2% per year).
In value terms, the largest prophylactic medicaments containing insulin suppliers to Panama were Free Zones ($X), Denmark ($X) and France ($X), with a combined 100% share of total imports.
Among the main suppliers, Free Zones, with a CAGR of +658.3%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced mixed trend patterns.
Import Prices by Country
In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, growing by 22% against the previous year. In general, import price indicated a modest expansion from 2012 to 2022: its price increased at an average annual rate of +1.2% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2017 an increase of 70%. The import price peaked at $X per ton in 2014; however, from 2015 to 2022, import prices failed to regain momentum.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Free Zones ($X per ton), while the price for Denmark ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Free Zones (+22.9%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Panama. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
- Panama
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Panama
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Asia.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in China.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the EU.
This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.
- Market Research in Panama
- Prophylactic Medicaments Containing Insulin Market
- Polymer Ion-exchangers Market
- Phenolphthalein and Lactones Market
- Hydantoin Market
- Malonylurea and Its Derivatives Market
- Compounds Containing A Pyrimidine Ring Market
- Compounds Containing An Unfused Triazine Ring Market
- Compounds Containing A Phenothiazine Ring-system Market
- Sulphonamides Market